Search

Prestige Consumer Healthcare

Suletud

SektorTervishoid

49.19 1.21

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

48.29

Max

50.29

Põhinäitajad

By Trading Economics

Sissetulek

7.2M

54M

Müük

-1.8M

282M

P/E

Sektori keskmine

12.54

62.58

Aktsiakasum

1.23

Kasumimarginaal

19.149

Töötajad

890

EBITDA

4.5M

85M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+46.85% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-8.7M

2.4B

Eelmine avamishind

47.98

Eelmine sulgemishind

49.19

Uudiste sentiment

By Acuity

50%

50%

145 / 340 Pingereas Healthcare

Prestige Consumer Healthcare Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. juuli 2026, 15:41 UTC

Prestige Consumer Healthcare Inc shares are lower today, diverging from broader market strength as no specific news was identified to explain the decline.

20. juuli 2026, 19:52 UTC

Prestige Consumer Healthcare Inc. is trading higher today, recovering from earlier lows. The stock remains near the upper end of its one-month range.

Võrdlus sarnastega

Hinnamuutus

Prestige Consumer Healthcare Prognoos

Hinnasiht

By TipRanks

46.85% tõus

12 kuu keskmine prognoos

Keskmine 72 USD  46.85%

Kõrge 72 USD

Madal 72 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Prestige Consumer Healthcare 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

2

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

145 / 340 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers analgesic powders under the BC and Goody's brand; diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and Debrox for ear wax removal. The company also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; Dramamine for motion sickness relief; enemas and other laxative products under the Fleet brand name; Gaviscon for upset stomach; cough drops under the Luden's brand; Monistat for yeast infections in women; Nix for lice and parasite treatments; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; TheraTears for dry eyes; nasal saline sprays and washes under the Fess brand name; and Hydralyte for oral rehydration. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
help-icon Live chat